Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre Non-interventional Study to Assess the Real-world Effectiveness of Ocrelizumab in Patients With Relapsing or Primary Progressive Multiple Sclerosis - The MuSicalE STUDY

NCT03593590 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT03593590
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03593590 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre Non-interventional Study to Assess the Real-world Effectiveness of Ocrelizumab in Patients With Relapsing or Primary Progressive Multiple Sclerosis - The MuSicalE STUDY
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
November 12, 2018
Completion date
January 19, 2026
Enrollment
1,710 (actual)
Sites
158

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis